                               SEQUENCE LISTING

<110> THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
 
<120> SHORT TAT OLIGOMERS FOR DRUG DELIVERY

<130> 16-50210-WO

<140>
<141>

<150> 62/517,472
<151> 2017-06-09

<160> 13    

<170> PatentIn version 3.5

<210> 1
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210> 2
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10  


<210> 3
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly 
1               5                   10      


<210> 4
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Cys Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10  


<210> 5
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Cys Arg Lys Lys Arg Arg Gln Arg Arg Arg Cys 
1               5                   10      


<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Cys 
1               5                   10      


<210> 7
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Cys Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly 
1               5                   10      


<210> 8
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Cys Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210> 10
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Cys Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Gln 
1               5                   10                  


<210> 11
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Gln 
1               5                   10                  


<210> 12
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Gln Gly Arg 
1               5                   10                  15      


Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Gln 
            20                  25              


<210> 13
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


